13F

Stock

Iovance Biotherapeutics, Inc.

IOVA · held by 3 managers

Reported value

$2.91M

Holders

3

+0 new · −1 exited

Holders’ est. mark

−$2.45M

Price effect on 2 books still in the name

Largest holder

$1.9M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC570.8K$1.9M−$2.32MCut−$2.67M
NORGES BANK260.1K$866.3KHeld
Henshaw Capital LLC41.8K$139.1K−$122.5KCut−$83.7K

Who left

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.